'6 95 ci 0' presentation slideshows

Chicago, Illinois | September 17-20, 2007

Key HIV Research From ICAAC 2007: The 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Faculty:. Chicago, Illinois | September 17-20, 2007. Cal Cohen, M.D., M.S. Eric Daar, M.D. This activity is supported by an educational grant from:. Faculty for This Activity.

705 views • 59 slides

Drowning

673 views • 48 slides

Plan

This sessions will be interactive. So please sit with people with whom you will enjoy a conversation. Plan. GRADE background two steps confidence in estimates (quality of evidence) strength of recommendation evidence profiles. Grading good idea, but which grading system to use?.

344 views • 19 slides

Corticosteroids in adults with bacterial meningitis

Corticosteroids in adults with bacterial meningitis. Diederik van de Beek Department of Neurology Netherlands Reference laboratory for Bacterial Meningitis Center of infection and Immunity Amsterdam (CINIMA) Academic Medical Center Amsterdam D.vandeBeek@amc.uva.nl.

358 views • 17 slides

Tony Burrell

300 views • 17 slides

Key HIV Research From ICAAC 2007: First-Line Antiretroviral Therapy and Switching Strategies

Key HIV Research From ICAAC 2007: First-Line Antiretroviral Therapy and Switching Strategies. Faculty:. Chicago, Illinois | September 17-20, 2007. Cal Cohen, M.D., M.S. Eric Daar, M.D. This activity is supported by an educational grant from:. Faculty for This Activity.

228 views • 12 slides

Key HIV Research From ICAAC 2007: First-Line Antiretroviral Therapy and Switching Strategies

Key HIV Research From ICAAC 2007: First-Line Antiretroviral Therapy and Switching Strategies. Faculty:. Chicago, Illinois | September 17-20, 2007. Cal Cohen, M.D., M.S. Eric Daar, M.D. This activity is supported by an educational grant from:. Faculty for This Activity.

206 views • 12 slides

Neda Esmailzadeh On behalf of HIVNAT 152 study team

Prevalence of insulin resistance and metabolic syndrome among HIV-infected children receiving lopinavir/ritonavir (LPV/r)-based antiretroviral therapy. Neda Esmailzadeh On behalf of HIVNAT 152 study team. A 48-week study of a randomized trial comparing the efficacy of

170 views • 3 slides

BACKGROUND

122 views • 1 slides